Work

The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB2 receptor activation

Year: 2024

Type: article

Source: Neuropharmacology

DOI: 10.1016/j.neuropharm.2024.110216

Authors: Antonio Matt Reck, David P. Siderovski, Steven G. Kinsey

Institutions: University of Connecticut, University of North Texas Health Science Center

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, U.S. Food and Drug Administration, National Institute on Drug Abuse, National Center for Complementary and Integrative Health

Awards: Stemming the opioid-induced pain cascade via cannabinoid modulation, Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics, The role of RGS12 in differential modulation of G protein versus beta-arrestin signaling downstream of the kappa opioid receptor

OpenAlex ID: W4404421452

FWCI: 0.283

Cites: 42

Cited by: 1

Related to: 10